Comparing carliprazine and aripiprazole for acute schizophrenia
Treatments studied
Part of Mental health clinical trials.
This study compares two medications, carliprazine and aripiprazole, to see which works better for people having an acute (sudden worsening) episode of schizophrenia. If you qualify, you will receive one of these pills for several weeks, and the doctors will check your symptoms closely to see how you respond.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Between 18 and 65 years old
- Diagnosed with schizophrenia
- Having moderate to severe symptoms (like delusions or hallucinations) that affect daily life
- Not currently in a severe episode that has required hospitalization for more than 3 weeks
- Not pregnant, breastfeeding, or willing to use birth control if female
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares lithium versus cariprazine to treat an episode of depression in people with bipolar disorder. It may help find which medicine works better and is safer during the acute (active) phase of depression.
This study tests how well a new aripiprazole injection works in your body compared to a standard version. You'll receive injections while your schizophrenia symptoms are stable, and researchers will measure drug levels in your blood to ensure the new version works the same way.
This trial compares two medicines, risperidone and cariprazine, to see which works better for treating acute mania in bipolar disorder. It aims to find a more effective option to help calm severe mood episodes quickly.
This trial tests a long-acting injectable form of cariprazine (AX251 LAI) for people with stable schizophrenia. You would receive one injection and stay at the clinic for 7 days to see how your body handles it and how well you tolerate it.
This trial tests a monthly injection of cariprazine (a medication for mental health conditions) in people who could benefit from it. It aims to see if the shot is safe, tolerable, and effective compared to taking pills every day.
This Phase 4 trial tests how well cariprazine works by itself to reduce symptoms of major depressive disorder (MDD). You may be eligible if you’re currently in a depressive episode and your depression score stays within a certain range at both screening and study start.
Hear when a new Acute Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.